Clinical Trial Update: A Vaccine Study for High Risk Cancers [Phase 1]

View source ↗

Summary

A Phase 1 cancer vaccine study has been withdrawn; it targeted neuroblastoma, rhabdomyosarcoma, and osteosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma
• Osteosarcoma
• Rhabdomyosarcoma

Snippet

Sponsor: Penn State University | Conditions: Neuroblastoma, Rhabdomyosarcoma | Phase 1 | Status: WITHDRAWN